# MSH6

## Overview
MSH6 is a gene that encodes the protein mutS homolog 6, a key component of the DNA mismatch repair (MMR) system in humans. The MSH6 protein functions as part of the MutSα complex, forming a heterodimer with MSH2 to recognize and initiate the repair of mismatched DNA bases and insertion-deletion loops during DNA replication. This protein is categorized as a DNA repair protein and plays a crucial role in maintaining genomic stability by preventing mutations that could lead to cancer. MSH6 is also involved in the repair of DNA double-strand breaks through the non-homologous end joining (NHEJ) pathway. Mutations in the MSH6 gene are associated with Lynch syndrome and other hereditary cancer predisposition syndromes, highlighting its clinical significance in cancer risk management (Shahi2010Mismatchrepair; Edelbrock2013Structural; Frederiksen2021Classification).

## Structure
The MSH6 protein is a crucial component of the DNA mismatch repair (MMR) system, forming a heterodimer with MSH2 to create the MutSα complex. This complex is responsible for recognizing and binding to mismatched DNA bases. The structure of MSH6 is divided into five conserved domains: mismatch binding, connector, lever, clamp, and ATPase domains. The mismatch binding domain interacts directly with mismatched DNA, causing the DNA to kink, while the ATPase domain is involved in conformational changes necessary for MMR function (Frederiksen2021Classification; Thirumal2019Elucidating).

MSH6 contains a unique N-terminal region (NTR) that includes a PWWP domain, which binds double-stranded DNA without preference for mismatches. This domain is characterized by a 5-stranded β-barrel and a large α-helix, and it is involved in interactions with chromatin modifications (Laguri2008Human). The N-terminal region is also rich in basic amino acids, facilitating electrostatic attractions to DNA, which are crucial for its mobility and sliding clamp activity (Edelbrock2013Structural).

The MSH6 protein also features a conserved Phe-X-Glu motif essential for detecting mismatches, with phenylalanine recognizing DNA distortion and glutamate forming hydrogen bonds with mispaired nucleotides (Edelbrock2013Structural).

## Function
The MSH6 gene encodes a protein that is a critical component of the DNA mismatch repair (MMR) system in humans. MSH6 forms a heterodimer with MSH2, known as the MutSα complex, which is responsible for recognizing and initiating the repair of base-base mismatches and insertion-deletion loops during DNA replication. This complex is particularly effective in repairing all eight types of base-base mismatches and insertion-deletion mispairs containing up to about 10 unpaired nucleotides (Iyer2005DNA). MSH6 is essential for maintaining genomic stability by preventing mutations that could lead to cancer (Edelbrock2013Structural).

In addition to its role in MMR, MSH6 is involved in the repair of DNA double-strand breaks (DSBs) through the non-homologous end joining (NHEJ) pathway. MSH6 interacts with Ku70, a protein involved in NHEJ, and accumulates at DSB sites, indicating its role in the early stages of DSB repair. MSH6-deficient cells exhibit reduced NHEJ activity and increased radiosensitivity, highlighting its importance in efficient DNA repair and cell survival following DNA damage (Shahi2010Mismatchrepair). MSH6 is primarily active in the nucleus, where it plays a vital role in maintaining genomic integrity (Edelbrock2013Structural).

## Clinical Significance
Mutations in the MSH6 gene are clinically significant as they are associated with Lynch syndrome (LS), a hereditary cancer predisposition syndrome. Individuals with LS have an increased risk of developing colorectal and endometrial cancers, among others (Hendriks2004Cancer; Frederiksen2021Classification). MSH6 mutations are also linked to constitutional mismatch repair deficiency (CMMRD) syndrome, which presents a different cancer spectrum, including brain tumors and hematological malignancies (Frederiksen2021Classification).

MSH6 mutations can lead to hereditary nonpolyposis colorectal cancer (HNPCC), characterized by a predisposition to colorectal and other cancers such as endometrial, small bowel, pancreatic, and ovarian cancers (Wu1999Association). These mutations are particularly associated with tumors displaying low microsatellite instability (MSI-low phenotype) (Wu1999Association).

In some cases, MSH6 mutations are linked to Turcot syndrome, which involves the development of colorectal carcinomas and primary central nervous system tumors (Hegde2005A). The clinical phenotype of MSH6 mutation carriers often includes a later age of cancer onset and a predominance of endometrial carcinoma (Hendriks2004Cancer). Genetic testing and counseling are crucial for managing the cancer risks associated with MSH6 mutations (Hendriks2004Cancer).

## Interactions
MSH6, as part of the MutSα complex, interacts with MSH2 to form a heterodimer essential for DNA mismatch repair. This complex specifically binds to DNA duplexes containing mismatched base pairs, with MSH6 acting as a specificity factor for repairing single-base-pair mismatches and loop insertions (Alani1996The). MSH6 also interacts with the proliferating cell nuclear antigen (PCNA), a trimeric DNA replication sliding clamp, through a conserved PCNA-binding motif in its N-terminus. This interaction enhances the binding of the MSH2-MSH6 complex to DNA containing mispaired bases and is crucial for mismatch repair during DNA replication (FloresRozas2000Proliferating; Edelbrock2013Structural; Friedhoff2016Protein-protein).

MSH6 is involved in DNA double-strand break repair through its interaction with Ku70, a component of the non-homologous end joining (NHEJ) pathway. This interaction is enhanced in response to DNA damage, suggesting a role for MSH6 in regulating NHEJ activity (Shahi2010Mismatchrepair). Additionally, MSH6 contains a PWWP domain that binds to double-stranded DNA, contributing to its role in DNA repair processes (Laguri2008Human). These interactions highlight the multifaceted role of MSH6 in maintaining genomic stability.


## References


[1. (FloresRozas2000Proliferating) Hernan Flores-Rozas, Delbert Clark, and Richard D. Kolodner. Proliferating cell nuclear antigen and msh2p-msh6p interact to form an active mispair recognition complex. Nature Genetics, 26(3):375–378, November 2000. URL: http://dx.doi.org/10.1038/81708, doi:10.1038/81708. This article has 183 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/81708)

[2. (Thirumal2019Elucidating) D. Thirumal Kumar, B. Susmita, E. Judith, J. Priyadharshini Christy, C. George Priya Doss, and Hatem Zayed. Elucidating the role of interacting residues of the MSH2-MSH6 complex in DNA repair mechanism: A computational approach, pages 325–350. Elsevier, 2019. URL: http://dx.doi.org/10.1016/bs.apcsb.2018.11.005, doi:10.1016/bs.apcsb.2018.11.005. This article has 10 citations.](https://doi.org/10.1016/bs.apcsb.2018.11.005)

[3. (Iyer2005DNA) Ravi R. Iyer, Anna Pluciennik, Vickers Burdett, and Paul L. Modrich. Dna mismatch repair: functions and mechanisms. Chemical Reviews, 106(2):302–323, December 2005. URL: http://dx.doi.org/10.1021/cr0404794, doi:10.1021/cr0404794. This article has 1158 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1021/cr0404794)

[4. (Friedhoff2016Protein-protein) Peter Friedhoff, Pingping Li, and Julia Gotthardt. Protein-protein interactions in dna mismatch repair. DNA Repair, 38:50–57, February 2016. URL: http://dx.doi.org/10.1016/j.dnarep.2015.11.013, doi:10.1016/j.dnarep.2015.11.013. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.dnarep.2015.11.013)

[5. (Hendriks2004Cancer) Yvonne M.C. Hendriks, Anja Wagner, Hans Morreau, Fred Menko, Astrid Stormorken, Franz Quehenberger, Lodewijk Sandkuijl, Pal Møller, Maurizio Genuardi, Hans van Houwelingen, Carli Tops, Marjo van Puijenbroek, Paul Verkuijlen, Gemma Kenter, Anneke van Mil, Hanne Meijers-Heijboer, Gita B. Tan, Martijn H. Breuning, Riccardo Fodde, Jull Th. Winjen, Annette H.J.T. Bröcker-Vriends, and Hans Vasen. Cancer risk in hereditary nonpolyposis colorectal cancer due to msh6 mutations: impact on counseling and surveillance. Gastroenterology, 127(1):17–25, July 2004. URL: http://dx.doi.org/10.1053/j.gastro.2004.03.068, doi:10.1053/j.gastro.2004.03.068. This article has 515 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1053/j.gastro.2004.03.068)

[6. (Hegde2005A) Madhuri R. Hegde, Belinda Chong, Maria E. Blazo, Lip Hon E. Chin, Patricia A. Ward, Murali M. Chintagumpala, John Y. Kim, Sharon E. Plon, and C. Sue Richards. A homozygous mutation in msh6 causes turcot syndrome. Clinical Cancer Research, 11(13):4689–4693, July 2005. URL: http://dx.doi.org/10.1158/1078-0432.ccr-04-2025, doi:10.1158/1078-0432.ccr-04-2025. This article has 67 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/1078-0432.ccr-04-2025)

[7. (Frederiksen2021Classification) Jane H. Frederiksen, Sara B. Jensen, Zeynep Tümer, and Thomas v. O. Hansen. Classification of msh6 variants of uncertain significance using functional assays. International Journal of Molecular Sciences, 22(16):8627, August 2021. URL: http://dx.doi.org/10.3390/ijms22168627, doi:10.3390/ijms22168627. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22168627)

[8. (Shahi2010Mismatchrepair) Ankita Shahi, Jung-Hee Lee, Yoonsung Kang, Sung Haeng Lee, Jin-Won Hyun, In-Youb Chang, Jae-Yeoul Jun, and Ho Jin You. Mismatch-repair protein msh6 is associated with ku70 and regulates dna double-strand break repair. Nucleic Acids Research, 39(6):2130–2143, November 2010. URL: http://dx.doi.org/10.1093/nar/gkq1095, doi:10.1093/nar/gkq1095. This article has 52 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkq1095)

[9. (Wu1999Association) Ying Wu, Maran J.W. Berends, Rob G.J. Mensink, Claudia Kempinga, Rolf H. Sijmons, Ate G.J. van der Zee, Harry Hollema, Jan H. Kleibeuker, Charles H.C.M. Buys, and Robert M.W. Hofstra. Association of hereditary nonpolyposis colorectal cancer–related tumors displaying low microsatellite instability with msh6 germline mutations. The American Journal of Human Genetics, 65(5):1291–1298, November 1999. URL: http://dx.doi.org/10.1086/302612, doi:10.1086/302612. This article has 215 citations.](https://doi.org/10.1086/302612)

[10. (Edelbrock2013Structural) Michael A. Edelbrock, Saravanan Kaliyaperumal, and Kandace J. Williams. Structural, molecular and cellular functions of msh2 and msh6 during dna mismatch repair, damage signaling and other noncanonical activities. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 743–744:53–66, March 2013. URL: http://dx.doi.org/10.1016/j.mrfmmm.2012.12.008, doi:10.1016/j.mrfmmm.2012.12.008. This article has 148 citations.](https://doi.org/10.1016/j.mrfmmm.2012.12.008)

[11. (Alani1996The) Eric Alani. The saccharomyces cerevisiae msh2 and msh6 proteins form a complex that specifically binds to duplex oligonucleotides containing mismatched dna base pairs. Molecular and Cellular Biology, 16(10):5604–5615, October 1996. URL: http://dx.doi.org/10.1128/mcb.16.10.5604, doi:10.1128/mcb.16.10.5604. This article has 125 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.16.10.5604)

[12. (Laguri2008Human) Cédric Laguri, Isabelle Duband-Goulet, Nikolas Friedrich, Marianne Axt, Pascal Belin, Isabelle Callebaut, Bernard Gilquin, Sophie Zinn-Justin, and Joël Couprie. Human mismatch repair protein msh6 contains a pwwp domain that targets double stranded dna. Biochemistry, 47(23):6199–6207, May 2008. URL: http://dx.doi.org/10.1021/bi7024639, doi:10.1021/bi7024639. This article has 41 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi7024639)